ATL, wish you were correct but I go with what Dr. Liau has said at her presentations before she got talking about the combination therapy trial. Imo these trials started as her group is seeking a way to help a greater % of patients. Not my problem if you are having difficulty understanding what she says, it does in some presentations mix what they are actually seeing and ideas on how they may try to improve the percentages Good luck
Dr.Richard Pazdur, Head of Oncology Center of Excellence - FDA 17:57
“Really, we don’t work for the regulations. We work for the US Govt and the US Govt are the patients, they are the community. And we have to always remember that we are not the American Statistical Association making decisions based on a P value. We have to weigh the risks and benefits of every application and every decision about what is in the best interest of the patients. And I always tell our staff that that should be our ultimate decision here. Is what is in the best interest of the patient in making a regulatory decision.
And if you keep that in mind, you will always be on the right side of history.”